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Abstract
Background: Telehealthcare involves the use of information and communication technologies to deliver healthcare at a
distance and to support patient self-management through remote monitoring and personalised feedback. It is timely to
scrutinise the evidence regarding the benefits, risks and costs of telehealthcare.
Methods and Findings: Two reviewers searched for relevant systematic reviews published from January 1997 to November
2011 in: The Cochrane Library, MEDLINE, EMBASE, LILACS, IndMed and PakMed. Reviewers undertook independent quality
assessment of studies using the Critical Appraisal Skills Programme (CASP) tool for systematic reviews. 1,782 review articles
were identified, from which 80 systematic reviews were selected for inclusion. These covered a range of telehealthcare
models involving both synchronous (live) and asynchronous (store-and-forward) interactions between provider and
patients. Many studies showed no differences in outcomes between telehealthcare and usual care. Several reviews
highlighted the large number of short-term (,12 months) feasibility studies with under 20 participants. Effects of
telehealthcare on health service indicators were reported in several reviews, particularly reduced hospitalisations. The
reported clinical effectiveness of telehealthcare interventions for patients with long-term conditions appeared to be
greatest in those with more severe disease at high-risk of hospitalisation and death. The failure of many studies to
adequately describe the intervention makes it difficult to disentangle the contributions of technological and human/
organisational factors on the outcomes reported. Evidence on the cost-effectiveness of telehealthcare remains sparse.
Patient safety considerations were absent from the evaluative telehealthcare literature.
Conclusions: Policymakers and planners need to be aware that investment in telehealthcare will not inevitably yield clinical
or economic benefits. It is likely that the greatest gains will be achieved for patients at highest risk of serious outcomes.
There is a need for longer-term studies in order to determine whether the benefits demonstrated in time limited trials are
sustained.
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Introduction
There is considerable international interest in the potential of
telehealthcare to improve the convenience, quality, safety and
cost-effectiveness of healthcare [1,2]. This has accompanied the
realisation that traditional models of health service delivery may be
unable to cope with future levels of chronic disease in ageing
populations [3,4,5,6]. Economic pressures on health systems also
call for solutions that will keep such patients out of hospital and in
their own homes for as long as possible [7,8]. Achieving
widespread telehealthcare is a key objective of the ‘Digital Agenda
for Europe’ and is a key feature of the UK’s NHS Information
Strategy [9,10,11]. It has also become a strategic priority for major
healthcare providers in the United States such as the Veterans
Administration, which aims to offer daily telehealthcare to over
28,000 of its members by 2014 [12].
We have previously defined telehealthcare as ‘‘the provision of
personalised health care over a distance’’ [13]. By personalised we
refer to the use of information and communication technology
(ICT) as a medium for enabling professional-patient interaction, in
contrast to more passive information delivery or monitoring
without feedback. Telehealthcare may be synchronous (real-time),
as in video-conferencing or telephone, or asynchronous, as with
email and other store-and-forward methods.
Despite the high levels of interest in telehealthcare, and
considerable industry hype surrounding its potential to reduce
healthcare costs and improve patient outcomes, there has not
always been adequate scrutiny of the scientific evidence base
underpinning it. We were commissioned by the National Health
Service Connecting for Health Evaluation Programme to review
this evidence, as part of a wider review on the quality and safety of
eHealth. The first part of our systematic overview was published in
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2011, focusing on electronic health records and computer decision
support systems [14,15,16]. This follow-on work involved identi-
fying, critically reviewing, summarising and interpreting the
evidence regarding the impact of telehealthcare on the quality
and safety of care [17].
Methods
Overview of Methods
In keeping with our related systematic overview [14], we chose
to conduct a systematic review of systematic reviews in order to
generate a high level synthesis of the evidence that offered the
potential to inform national and international policy deliberations
with regard to telehealthcare applications.
Developmental Work
There are many terms used to describe the remote delivery of
care: ‘‘telehealth’’, ‘‘telecare’’, ‘‘telemedicine’’ and ‘‘home
telemonitoring’’ are among the most often used. We reviewed
many definitions of these terms and placed them within a
conceptual framework [17,18]. We have chosen to use the term
‘‘telehealthcare’’ to describe the interaction, over a distance,
between a patient and a health care professional. Synchronous
models of telehealthcare involve real-time interactions, (e.g.
telephone or video-conferencing with or without physiological
monitoring), while asynchronous telehealthcare models use store-
and-forward methods, such as Short Message Service (SMS),
email consultation or monitoring of symptoms and signs
through networked devices that collect and upload data at
intervals. We were interested in both synchronous and
asynchronous models of telehealthcare.
While synchronous methods of consulting are often used to
overcome barriers of physical distance, strategies for the manage-
ment of long-term conditions are increasingly focused on
supporting patient self-care through enabling remote measure-
ment of symptoms, either through questionnaires or through
monitoring devices which transmit data (e.g. blood glucose, blood
pressure, weight, electrocardiogram) via telephone, Internet or
mobile network to one or more healthcare professionals who
review the data and then use their clinical judgement to make
recommendations and deliver patient-specific feedback to the
individual [13].
Telehealth models involving automated, algorithm-driven
feedback in response to self-monitoring data (as in self-testing of
blood pressure with numerical feedback or computer-generated
guidance) were not included within this review. Also outside of the
scope of this review were the use of distance technologies to
facilitate communication between healthcare professionals (often,
although not exclusively, referred to as ‘‘telemedicine’’), medical e-
learning or one-way online health information interventions/
portals.
Search Strategy
We searched The Cochrane Library, MEDLINE, EMBASE,
LILACS, IndMed and PakMed for systematic reviews published
from January 1997 to November 2011 to identify those
investigating the impact of telehealthcare interventions on the
quality and safety of care. We drew on the comprehensive list
of Medical SubHeadings (MeSH) and free text terms covering
the concepts of ‘‘quality’’ and ‘‘safety’’ which we had developed
for our earlier overview [14]. These sets of terms were
combined with MeSH and key words related to the concept
of ‘‘telehealthcare’’ and with the methodology terms ‘‘systematic
review or meta-analysis’’ (see S1 Supplement 1 Search Strategy).
We also searched Google Scholar and the University of York’s
PROSPERO database for further published and unpublished
material, using modified search strategies.
Selection of Systematic Reviews
At least two reviewers (SM, UN or KC) independently assessed
the retrieved studies for inclusion against our inclusion/exclusion
criteria and reached agreement through discussion. If agreement
could not be resolved in this way a further reviewer (CP)
arbitrated.
Inclusion Criteria
The only study design that was eligible was that of a systematic
review. We identified these as studies referring to themselves as
systematic reviews in the title or abstract, or studies which used
systematic review methodology on closer inspection of the
methods section. We did not consider the different types of study
designs included within the systematic reviews, as these were very
varied. The interventions described by the review had to fall
within our definition of telehealthcare as personalised feedback
delivered by a healthcare professional in response to patient-
specific data via ICT.
Exclusion Criteria
We excluded diagnostic or treatment advice from subject
experts (e.g. telepathology/teledermatology) and conferencing
between healthcare professionals. Also excluded were examples
in which health professionals were gaining mobile access to
records, evidence or computerised decision support without a
patient-to professional-interaction. Online forums and peer groups
were excluded unless there was evidence that a healthcare
professional was making personalised recommendations to the
forum to support individual patients. Systems that provided only
automated, computer-driven, feedback in response to patient self-
monitoring data were also excluded.
Critical Appraisal of Systematic Reviews
Two reviewers (SM, KC) independently assessed the quality of
each of the included systematic reviews using the Critical
Appraisal Skills Programme (CASP) tool (see S2 Supplement 2
CASP Score Tool) [19]. Reviewers discussed areas of disagree-
ment and resolved these through discussions to agree moderated
scores. In cases where it was not possible to reach agreement, a
third reviewer arbitrated (CP). With the assistance of UN, MM
and AH, none of the authors were involved in data extraction or
quality appraisal of their own previous work.
Data Synthesis
We abstracted key information regarding telehealthcare
interventions from the body of systematic reviews, having
piloted several data-extraction templates, concentrating on
different clinical areas of practice and categories of evidence
according to our conceptual frameworks. We systematically
extracted data on the key benefits and risks of telehealthcare.
This involved identifying benefits in clinical endpoints to
patients, then benefits in terms of patients’ quality of life, and
other benefits for patients. Benefits for professionals and benefits
for the healthcare system were also identified and any other
benefits. Finally, we reviewed risks for patients, professionals or
the healthcare system.
The Impact of Telehealthcare
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Results
Overview of the Evidence
Searches undertaken as part of our previous work identified
1716 potentially relevant reviews from which we selected 41
systematic reviews which focused on telehealthcare [17]. Re-
running the searches to cover the period up to and including
November 2011 resulted in a total of 81 systematic reviews
meeting our inclusion criteria (see S3 Supplement 3 PRISMA
Figure).
The 81 systematic reviews synthesised evidence from 2,396
original articles, excluding duplicates, including 579 randomised
controlled trials (see S4 Supplement 4 Studies Figure). The focus of
each review was variable. Most focused on a specific disease area.
However, there were also reviews focusing on telehealthcare in the
frail elderly [20,21], patient satisfaction [22,23,24], telephone
consultation [25,26,27], video-conferencing [28,29], rural tele-
healthcare [30] and telehealthcare in Asian countries [31]. In this
article, when we use the term ‘‘review’’ we are referring to the
included 80 systematic reviews that have been quality appraised;
when we discuss ‘‘studies’’ we are referring to the studies included
within the reviews themselves.
Telehealthcare was involved in the ongoing management of
various long-term conditions and there were seven reviews on this
subject [21,28,32,33,34,35,36]. There were eight reviews which
specifically examined the role of telehealthcare in caring for
diabetic patients [37,38,39,40,41,42,43,44], six reviews solely on
chronic heart failure [45,46,47,48,49,50] and eight reviews on
mental disorders including drug addiction
[51,52,53,54,55,56,57,58,59]. There were two reviews (published
in three reports), concerning asthma [60,61,62] and two on
chronic obstructive pulmonary disease (COPD) [63,64]. In such
systematic reviews, telehealthcare was used to monitor the
patient’s condition; frequently by relaying questions about
symptoms such as breathlessness and prompting measurement of
other parameters such as weight and blood glucose. Telehealth-
care was also used to deliver advice to the patient, either to change
treatments or to modify the frequency of monitoring. In the area of
mental health, telehealthcare was used to deliver cognitive
behavioural therapy from a distance, often via videoconferencing
or telephone, but there were also trials of computer-based
cognitive therapy delivered as part of a package of therapist-
guided interventions.
Quality of Evidence
The evidence amassed was generally of moderate quality, with
the majority of studies scoring between 15 and 25 out of 30
according to the CASP criteria (see S5 Supplement 5 Summary
Table [19]). Several reviews highlighted the predominance of
small pilot-like studies with fewer than 20 subjects [20,22,65,66].
Such studies were mainly useful for demonstrating the feasibility of
the technology. Some of the studies included in the reviews did not
report power calculations, placing them at risk of Type II errors
[66]. Often reviews contained studies that were not randomised or
that were designed as observational studies, pilot studies or pre-
post studies, limiting the weight that can be given to their
conclusions
[21,22,23,24,26,28,29,31,33,34,35,36,38,40,41,42,43,48,49,52,58-
,67,68,69,70,71,72,73,74,75,76,77]. A number of reviews did not
clearly detail the study designs of all the included studies
[20,30,32,51,60,78,79,80,81,82,83,84,85,86]. In one review the
number of studies included was not clear [60].
Clinical Outcomes
Surrogate endpoints. Many government and industry
claims made around the benefits of telehealthcare include
reduction of mortality, morbidity, frequency of hospitalisations
and number of bed days of care. We searched for these ‘hard’
clinical endpoints, but we found instead that many reviews of
telehealthcare reported ‘surrogate’ endpoints such as changes in
mean HbA1c, blood pressure and lipid profile
[37,38,39,40,41,42,43,44]. The advantage of evaluating surrogate
endpoints is that smaller, shorter trials may be undertaken. The
authors of such studies often infer that as it is ‘‘known’’ that, for
example, improving HbA1c improves diabetes related hard
clinical outcomes such as the incidence of myocardial infarction
and strokes, there is no need to repeat that finding [87,88]. We
often encountered a situation where a result was reported as of
statistical significance, but where its clinical significance was
equivocal [22,38,51,53,65,68,71,78,84,89].
The reviews yielded some examples of studies showing small
improvements in surrogate endpoints for long term conditions. In
diabetes, there were small but statistically significant pooled
decreases in HbA1c - In Type 1 diabetes (20.4% difference, 95%
C.I. 0.0 to 20.8) [40] and Type 2 diabetes (20.6% in HbA1c
[39]), (weighted mean difference, 20.2%, 95% C.I. 20.4 to 20.1
[41]). One review did not pool results but reported that a reduced
HbA1c was demonstrated in six trials [42]. Another two reviews
reported that there was no difference in HbA1c in a pooled
statistic from 19 randomised controlled trials (weighted mean
difference 20.1%, 95% C.I. 20.4 to 0.2) [43] and in a pooled
statistic from seven trials (weighted mean difference of 20.4%,
95% C.I. 20.9 to 0.1). Overall, the data suggested that these
interventions had at best only modest effects on blood glucose
control.
Two systematic reviews focused on home management of blood
pressure by patients with hypertension [78,90]. In one review of 22
trials there was a small change in the pooled mean systolic BP of
22.6 mmHg (95% C.I. 24.2 to 21.0) and in the pooled mean
diastolic BP of 21.7 mmHg (95% C.I. 22.6 to 20.8) [78]. In
another review, office blood pressure improved significantly more
in patients randomised to home telemonitoring: systolic
25.7 mmHg (95% C.I. 27.9 to 23.4), diastolic 22.8 mmHg
(95% C.I. 23.9 to 21.62) pooled across 11 studies. However, the
differences in ambulatory blood pressure were less marked:
systolic: 22.3 mmHg (95% C.I. 24.3 to 20.2); diastolic
1.4 mmHg, no difference (95% C.I. 23.6 to 0.8) [90] Again,
these differences are small, raising questions about their clinical
relevance.
In summary, there were some small statistically significant
improvements reported in surrogate endpoints but these were not
consistent across all studies and unlikely to have significant clinical
impact.
Hard clinical endpoints. It is important to see if any
improvements in surrogate endpoints can be translated into
improvements in hard clinical endpoints, such as mortality.
The strongest evidence in this respect is in relation to chronic
heart failure. There were several studies looking at mortality in the
context of telehealthcare for heart failure patients [45,46,49,50].
One review searched for studies which compared home tele-
monitoring to usual care and found reduced all-cause mortality
[49]. The authors pooled data from five randomised controlled
trials and one observational study. The pooled relative risk was 0.6
(95% C.I. 0.5 to 0.8). In another review which specifically only
included trial arms that compared telemonitoring to usual care
and excluded arms with nurse only support or telephone support,
reviewers also found a reduction in all-cause mortality based on 10
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studies, relative risk 0.8 (95% C.I. 0.6 to 1.0) [45] A Cochrane
review described the telehealthcare intervention as a multi-
disciplinary care model typically involving ICT and which may
include self-monitoring and education [46]. It classified interven-
tions as ‘‘structured telephone support’’ if the monitoring and/or
self-care management was delivered using simple telephone
technology (although data may have been collected and stored
by a computer) and ‘‘telemonitoring’’ if there was digital/satellite/
broadband/wireless or Bluetooth transmission of physiological
data. The Cochrane reviewers further defined the intervention as
having to have been initiated by a healthcare professional and
delivered to patients with chronic heart failure in the community
as the only aftercare intervention, without home visits or
intensified clinic follow-up. The comparison was usual care
without intensified attendance at cardiology clinics or clinic-based
chronic heart failure disease management programme or home
visiting. In the pooling of all-cause mortality data from 15 studies
structured telephone support resulted in a non-significant relative
risk of 0.88 (95% C.I. 0.76 to 1.01) [46] and telemonitoring
resulted in a significant relative risk of 0.66 (95% CI 0.54 to 0.81).
And so overall it is probable that mortality from heart failure can
be reduced with telemonitoring, but not with structured telephone
support.
There were two reviews that reported on clinical endpoints by
meta-analyses of randomised controlled trials of home-based,
secondary rehabilitation programmes for coronary artery disease
following acute myocardial infarction or coronary artery bypass
graft [70,91]. The first review by Clark et al [91], did not pool
studies according to the intervention (classified as paper-based,
electronic, telephone or home visit) but according to the setting
(hospital- or home-based rehabilitation) and outcome (all-cause
mortality, cardiovascular events, quality of life and risk factors).
This makes it very difficult to draw conclusions as to the usefulness
of the different interventions as ‘‘home-based rehabilitation’’ could
involve a manual, the telephone and/or home visits. However, in
pooling six studies with the outcome of mortality there was no
difference between home-based interventions versus in-hospital
cardiac rehabilitation. In the second review by Dalal et al [70],
home-based cardiac rehabilitation was defined as a structured
programme with clear objectives for the participants, including
monitoring, follow-up, visits and telephone calls, and this was
compared with centre based cardiac rehabilitation where a
supervised group based in a hospital or community setting
underwent rehabilitation. Dalal et al found no difference in
mortality (relative risk 1.3 95% C.I. 0.7 to 2.7) [70] and no
significant difference in cardiovascular events (stroke, transient
ischaemic attacks and heart failure). There was also no difference
in secondary prevention of coronary heart disease mortality with a
telephone-mediated health behaviour change programme [92,93].
A review of patients having telephone follow-up after cancer,
compared to those having a face-to-face follow-up assessment, also
showed no differences in mortality [83]. The telephone follow-up
consisted of an interview carried out by a healthcare professional
and patients were given a choice of using the telephone as part of
their package of care. This review included 11 articles and
described two trials where recognition of symptoms over the
phone versus a face-to-face appointment was said to be equal: one
trial was in breast cancer and the other was for urological
symptoms. However, in these trials it was not clear to what extent
the symptoms were recognised and assessed over the phone, nor
was it apparent what the threshold for having a face-to-face
appointment was following a phone assessment, nor whether such
an appointment would be with a doctor or nurse or feature
additional tests such as ultrasound.
The reviews of interventions for mental health investigated a
variety of different clinical endpoints including diagnostic and
symptom scores. Computerised cognitive behavioural therapy,
with health professional oversight, had a positive impact in major
depression according to the statistical measure used, but effects for
social phobia panic disorder and generalised anxiety disorder were
non-significant [94]. Telephone therapy for mild depression also
improved symptom scores in one small study that was included in
another review [53]. A review of Internet-based programmes for
anxiety and depression in children and adolescents found
symptom reduction and improvement in diagnostic ratings in six
of the eight evaluation studies (three randomised controlled trials,
two non-randomised controlled studies, two pre-post studies and
one other study). There were two Internet-based programmes both
supported by healthcare professionals either within the medical
setting or remotely by email or telephone, who motivated users
and supported their use of the programme, but no details of
supervision for the other programmes were given [52]. Another
review of computerised cognitive behavioural therapy for the
prevention and treatment of depression and anxiety in children
and adolescents included five randomised controlled trials and five
case series and found that the percentage of participants meeting
the diagnostic criteria for depression fell from 100% at the start of
treatment to 30–78% post-treatment with the intervention. This
review reported reductions in diagnostic severity, numbers of co-
morbid diagnoses and anxiety and depressive symptoms [58].
However another review reported that only four out of eight
studies showed a significant symptom reduction when compared to
a control group [59]. Therefore, for mental health it seems that
telehealthcare can result in small, significant benefit in symptoms.
Synchronous telehealthcare, such as video-conferencing, was
suitable for the delivery of some rehabilitation techniques after
stroke and spinal cord injury [75,84]. However, conclusions
regarding the effectiveness of telerehabilitation are premature as
only 13 of the 56 included experimental studies involved a group
of more than 20 patients, and not all of these studies were of robust
design [75].
Several reviews commented that one advantage of telerehabil-
itation following stroke is that patients can access rehabilitation
even if they live in a remote area. However, it was not clear from
the presentation of the studies in the rehabilitation reviews
whether the control groups were receiving standard outpatient
rehabilitation or no rehabilitation [28,73,74]. There have been
trials involving upper and lower limb rehabilitation, carer support
and problem solving skills using video-conferencing and the
Internet. In one review, there were four randomised controlled
trials and four case series. It was not clear what the comparison
groups were in the trials [73]. Another review included small
studies of rehabilitation for a very diverse group of patients
including: community elderly who had had falls or poor mobility,
post total-knee replacement, post admission to geriatrics, knee
pain, stroke, assessment for home care, multiple sclerosis,
traumatic brain injury patients, post myocardial infarction, post
cardiac surgery, spinal cord injury patients, speech and voice
disorders, gait disorders, prosthetics, high care residents in
residential care, and chronic pain. Outcomes were reported to
be similar to those with face-to-face rehabilitation, with similar
drop-out rates. There was some suggestion of decline in outcomes
with longer term follow-up, but findings were inconsistent [74]. It
was also reported that patients were more accepting of videocon-
ferencing than staff [28].
In asthma, improvements in peak flow rates and symptoms were
not consistently demonstrated with daily interactive monitoring
and educational tools via the Internet [60,61].
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In COPD, there was no change in mortality with telehealthcare
in a pooling from three trials (odds ratio 1.05 95% CI 0.63 to
1.75). The interventions in two of these three trials consisted of a
web-based patient record with videoconferencing, or a web-based
call centre with weekly phone calls and a co-ordinating case-
manager. There was evidence from the third randomised
controlled trial of a reduction in exacerbations, however, the
intervention in this trial was well-resourced and complex including
education and visits from nurses as well as telephone support [64].
There was also no change in mortality in this trial.
Therefore the evidence demonstrating improvements in hard
clinical endpoints due to telehealthcare is modest and context-
dependant. In general the evidence suggests that telephone only
support models give results that are no better or worse than face-
to-face. However, complex integrated interventions involving
telemonitoring, education and additional support, potentially
including home visits (which was not part of our telehealthcare
definition) do have the potential to modestly improve outcomes.
Health Service Utilisation
A decrease in the utilisation of healthcare services is often taken
as an indicator of improved efficiency and quality in telehealthcare
studies, for example through the replacement of face-to-face
consultations with remote ones, or through reductions in hospital
bed-days or emergency department visits as a result of better
patient monitoring.
With regard to chronic heart failure: the Cochrane review of
chronic heart failure reported a small significant reduction in all-
cause hospitalisations for both structured telephone support
compared with usual care (relative risk 0.9 (95% CI 0.9 to 1.0)
and for telemonitoring compared with usual care (relative risk 0.9
(95% C.I. 0.8 to 1.0) [46]. In terms of chronic heart failure related
hospitalisations, again both structured telephone support (relative
risk 0.8, 95% C.I. 0.7 to 0.9) and telemonitoring (relative risk 0.8,
95% C.I. 0.7 to 0.9) demonstrated significant reductions [46].
Another review which focused on telemonitoring, pooled results
for chronic heart failure from six studies for all cause hospital
admission did not find a reduction for this outcome (risk ratio 1.0,
95% C.I. 0.9 to 1.0) [45]. However, for telemonitoring for chronic
heart failure related hospital admission there was a significant
reduction (risk ratio 0.7, 95% C.I. 0.6 to 0.9). A third review also
found significant evidence of reduced all cause hospitalisations
(incidence rate ratio 0.9, 95% C.I. 0.8 to 1.0) and chronic heart
failure related hospitalisations (incidence rate ratio 0.8, 95% C.I.
0.7 to 0.9) [47]. This review pooled results for all kinds of remote
patient monitoring in the form of either regular structured
telephone contact between patients and healthcare providers,
with or without a home visit, or technology assisted monitoring
with transfer of physiological data and those with usual care
consisting of patient visits to an outpatient clinic without additional
phone calls [47]. A fourth meta-analysis reported significantly
fewer all-cause hospitalisations with home telemonitoring in
comparison with usual care, (relative risk 0.8, 95% C.I. 0.7 to
0.9) [49]. Another review reported decreased re-hospitalisation
rates in patients with telemonitoring for heart failure [67]. Overall,
it would appear that there is substantial evidence that telemonitor-
ing reduces the risk of hospital admission in chronic heart failure.
The evidence as to whether telephone support also reduces this
risk is less clear cut.
In asthma there was significant reduction in hospitalisations
over a 12 month period across four studies with a variety of
telehealthcare interventions, including web-based diary and
interaction with professionals, telephone calls from a nurse
educator, telemonitoring with oversight for severe asthma and
electronic diary with email or telephone follow up from a
physician (risk ratio of 0.3 (95% C.I. 0.09 to 0.7) [61,62]. These
four studies were dominated by two studies in which the
participants had severe and poorly controlled asthma and would
appear to suggest that the more severe the patients’ condition the
more they stand to benefit.
Two reviews reported reduced hospitalisations in COPD, again
there was a variety of heterogeneous telehealthcare interventions
pooled together, from simple repeated telephone support to
complex interventions including education, telemonitoring and
home some home visits [63,64].
Two reviews of mixed chronic conditions concluded that the
majority of included studies reported a significant decrease in
emergency department visits, hospital admissions, and hospital
length of stay for patients with heart and lung diseases [34,36].
The first of these two reviews concentrated on home telemonitor-
ing as an automated process for the transmission of data on a
patient’s health status from home to the respective healthcare
setting and included 65 studies but did not detail the interventions
individually [34]. The second review was performed for the
Canadian Agency for Drugs and Technologies in Health and
classified interventions as either telemonitoring, involving data
transmission and audio or video monitoring or telephone support,
involving only telephone calls, they included 78 studies. For
diabetes, heart failure and COPD they reported findings that there
was evidence of reduced hospitalisations with both types of
technology [36].
Similarly, a review of diabetes studies reported an average
decrease in consultation time and decreased hospital admissions
[43]. In this review the interventions were particularly targeted at
monitoring clinical values and education. Diverse technologies
were used for monitoring data, including palm-tops, glucometers,
mobile phones and digital cameras, there was videoconferencing
in some studies and others used web based disease management
systems with multi-access capability. Another review of diabetes
studies also reported a reduced number of patients hospitalised
with telephone support, but found no studies of home-telemoni-
toring systems. [41].
Patterns of healthcare use changed significantly in some of the
studies that compared face-to-face follow up for colorectal cancer
with telephone follow up. Waiting times for a specialist appoint-
ment in one study dropped from 12 to 4 weeks and the incidence
of patients failing to attend outpatient appointments decreased by
50%. Patients felt able to contact nurses for advice between
appointments, which would also have implications for workload
[83].
Telephone therapy did not make a statistically significant
difference to hospital readmission for schizophrenia in one review
of mental health [53].
One review reported reduced bed-days and emergency
department visits for the elderly with chronic conditions, due to
regular vital signs monitoring. However, it was not clear from the
review how this monitoring was supervised [21].
A review of telephone follow-up initiated by a hospital-based
health professional for post-discharge problems in patients
discharged from hospital to home reported 11 studies examining
health services related outcomes. Eight studies reported no
difference, two studies reported fewer readmissions in the
intervention group [25]. Of these two studies, one featured
telephone follow-up for cardiac rehabilitation and the other, larger
study (n= 242) was with telephone and computer decision support
for people with chronic heart failure.
Overall, there appear to be many examples of telehealthcare
reducing hospitalisations. Again there is a need for more context
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description to be given in studies regarding the specific nature of
the interventions. We found some evidence that telemonitoring is
probably more consistent in reducing hospitalisations than simple
telephone support alone.
In general there was insufficient information included in the
reviews to enable categorisation of patients by the severity of their
illness. However, it would seem that where patients are more ill,
e.g. with severe asthma rather than mild asthma, they stand to
have more to gain from the interventions. This makes sense
because applying the same relative risk reduction to those with a
greater absolute risk of hospitalisation will result in a greater effect.
Quality of Life
One review reported improvement in quality of life outcomes
for some patients, for example in chronic heart failure and in
asthma, but no improvement in diabetes [21].
The Cochrane review of heart failure reported that quality of
life was a secondary outcome for 15 studies altogether, with nine
studies reporting improvement in quality of life [46]. In another
review of heart failure some studies included scores on SF-36 and
the Minnesota Living with Heart Failure score, both of these
improved, however the other included studies did not demonstrate
an improvement in quality of life [45].
Several different quality of life scales were employed by the
studies included in a review on the psychosocial outcomes of
telephone-based counselling for adults with an acquired disability
[84]. Most did not detect a significant difference following
telecounselling compared with normal counselling.
There were no improvements in pooled quality of life in asthma
with telehealthcare [62]: (mean difference 0.1, 95% C.I. 0.001 to
0.2) and none of the pooled nine studies individually measured a
significant improvement in quality of life either. This may be
because Juniper’s Asthma Quality of Life Questionnaire being
relatively unresponsive to change.
In COPD, there was a significant increase in pooled quality of
life in telehealthcare compared to control, (decrease means
improvement, minimally clinical significant improvement 24.0
points) (mean difference 26.6, 95% C.I. 213.7 to 0.5). This meta-
analysis pooled only two studies both of which featured an
integrated complex intervention with case manager, education,
information technology and telephone support. It seems that such
intensive interventions were successful.
Reviews often did not report what quality of life scales had been
used, but made general statements regarding specific studies:
maternal fatigue was reduced by telephone counselling for
behaviourally difficult infants and videoconference for parents of
very low birthweight infants could improve quality of life by
providing emotional support and education to parents [72].
Patients who had Internet access to discussion forums where
specialists could respond and feedback to queries had benefits
across a range of quality of life outcomes, including higher
cognitive functioning, lower negative emotions, more active
lifestyle and greater social support [32]. Such benefits became
apparent at two months and became sustained after six months.
In diabetes, one review found benefits to quality of life, self-
efficacy and social advantages [39], whereas another reported that
quality of life was similar in the intervention arm to the usual care
arm [41].
The reviews indicated above reported improved quality of life
with different forms of telehealthcare. In addition, there was still a
substantial minority of reviews in which quality of life was reported
as not improved: [36,43,50,86,93].
Satisfaction and Other Soft Outcomes
One review compared patients who used telephone contact for
consultations with ordinary face-to-face consultations. It found
four studies that reported patient satisfaction [22]. Two studies
found no significant difference and the other two found that
patients who had used telephone contact were more satisfied.
Patients who used telephone follow-up for colorectal cancer
were largely satisfied. They also reported reduced travel time and
costs and increased convenience [83]. In a large Canadian review
of different types of asynchronous telehealthcare it was found that
patient satisfaction was generally higher in rural than urban areas
and 76% of patients preferred to be assessed by telehealthcare
than wait longer for an in-person consultation [69].
Another review of different types of telehealthcare in mixed
chronic diseases found that, although clinical outcomes did not
improve significantly, patients were overwhelmingly satisfied with
the technology. In one study they rated telehealthcare an average
of 4 out of 5 on a Likert scale [51].
One review which concentrated on patient satisfaction in
telehealthcare for chronic heart failure commented that the
description of the definition of patient satisfaction was poor and
measured in many different ways with poorly constructed
instruments. The authors concluded that this could be improved
if interventions were more theoretically-based and standardised
and validated instruments in accordance with the American Food
and Drug Administration’s recommendations [48].
Patients reported that tele-rehabilitation was convenient and
useful [74]. There were also moderate-to-high ratings for
participant and parent satisfaction in the review of computerised
cognitive behavioural therapy for the prevention and treatment of
depression and anxiety in children and adolescents [58].
Overall, it seems that the majority of reviews did not comment
on satisfaction, however, where such outcomes had been assessed,
it was largely positive. An important criticism raised in one of these
revews was that the majority of studies did not define what
satisfaction meant and it was not clear if patients were satisfied
because the intervention did them no harm or because it was of
clear positive benefit. A positive bias may also have been present as
a result of the novelty factor of the technology as few studies
explored what happened to satisfaction over time [23].
Safety
There was very little in the systematic reviews specifically
concerning patient safety and it was not clear whether adverse
events did not occur or whether there was a lack of reporting.
Costs and Cost-Effectiveness
There was only one review formally examining the cost-
effectiveness of telehealthcare [77]. It reviewed the 55 studies
found by searching for ‘‘cost-effectiveness’’ in association with
‘‘telehealth’’ in appropriate databases and reported that 24 studies
included formal trial data, the remainder being hypothetical or
modelling studies. Of these 24 studies, most evaluated cost-
effectiveness from the perspective of the health service, while only
four undertook an evaluation encompassing the broader societal
perspective. Comparisons of the cost of the telehealthcare
programmes were absent from two studies and were hypothetical
in nine studies. In addition, the authors criticised the techniques
used by the majority of studies for calculation of costs and benefits
as inappropriate. Overall, cost-effectiveness research was very
poor, as it was of small scale and short duration [77]. Many studies
included only limited data on financial outcomes and did not fully
cost the telehealthcare service [77]. For example, the costs of
additional staff required to manage the telehealthcare service were
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not included. Such additional staff had often clearly contributed to
the effectiveness of the telehealthcare intervention [37,74].
Another review also noted that costs and cost-effectiveness were
overwhelmingly considered only from the narrow perspective of
the health care provider [72]. In general, the reviews did not
provide the evidence to support the optimistic policy rhetoric
regarding large potential savings to be enabled by telehealthcare.
Discussion
Summary of Findings
The evidence-base represented by existing systematic reviews of
telehealthcare research covers diverse types of interventions
involving a wide range of outcomes and target groups. The
reviews themselves varied in quality. Across the field, the quality of
primary studies appears to be generally low, with many studies
involving small numbers of patients and lasting for short periods,
thus limiting their power to detect meaningful differences in
outcomes. Few studies rigorously examined cost-effectiveness
whilst even fewer undertook comprehensive economic evaluations
that encompassed financial impacts on patients in addition to
health services. We did not come across any studies that explicitly
examined impacts of telehealthcare on patient safety. Synthesising
this evidence base was complicated by the variability in
terminologies used to characterise different types of intervention
and a general poverty of information about the intervention
delivered and its context of use, which muddies the interpretation
of results.
Many studies have reported small, statistically significant
improvements in surrogate endpoints as a result of telehealthcare
interventions, but larger studies of longer duration are needed to
determine whether these will be sustainable and translate into
improved hard clinical endpoints. There is some evidence that
telehealthcare can reduce mortality in chronic heart failure, but no
reduction in mortality had been demonstrated for any other
chronic condition during the period covered by these reviews. The
reduction in heart failure mortality may be due to a general
optimisation of medical care in these patients and it is not yet
known whether such a reduction persists beyond the first year of
telehealthcare. There is some evidence of symptom improvement
in depression with tele- cognitive behavioural therapy.
There is stronger evidence that telehealthcare can reduce the
frequency of hospitalisation in chronic heart failure, chronic
respiratory conditions and diabetes. These improvements appears
to be greatest in patients at high risk of mortality and
hospitalisation, who may be telemonitored closely to ensure that
signs of deterioration are identified early so that steps can be taken
to avert the need for admission. Longer term studies are required
to see if this prevention of admission will result in reduced
mortality or will simply shift the burden of care from hospitals to
communities, while the broader economic impacts of prolonging
life in high dependency populations is a matter for ethical debate
in our aging society.
In some cases, complex telehealthcare interventions included
expanded roles for nursing staff in order to reduce the burden on
more costly physicians [95]. However, such healthcare profession-
als require training to support new responsibilities and maintain
accountability, and protocols to clarify workflow, each of which
may require additional expenditure. This highlights the important
costs involved in setting up a new telehealth service, which also
include technology purchase, support and service redesign, which
may outweigh the economic benefits of reduced hospitalisations or
other health service outcomes in the short term. It is arguable that
the cost benefit ratio may improve over time as services become
embedded and efficiency savings accrue.
Telehealthcare services were usually organised along hospital-
style disease definitions, often with a specialised nurse reporting
back to a hospital consultant. This has the potential to result in
more disease-oriented and less holistic, patient-oriented care,
which is problematic in light of the increased prevalence of multi-
morbidity with old age [96]. The reviews did not discuss how, for
example, a frail elderly patient with more than one chronic illness
would navigate between the specialist services available to them.
Strengths and Limitations
This systematic overview benefits from the breadth of searches
undertaken and the depth of the initial conceptual work that
informed it [17,18]. In addition to the usual searches of
international medical and scientific databases, databases covering
literature from the developing world were searched in order to
capture emergent findings from low and medium income settings,
although this yielded few results, highlighting the limited coverage
and transferability of the existing evidence-base [31,60]. In
contrast to a recent overview by Ekeland et al [97], the data
collection in this overview was completed by two reviewers and the
data extraction form was piloted several times in several different
forms before an optimal form was selected. The quality of the
reviews was assessed with reference to a standardised checklist and
all review scores were moderated by a second reviewer.
Overviews, or ‘meta-reviews’ such as this are relatively new type
of study and attempt to make sense of a broad and deep primary
evidence base [98]. The method is most useful for a policy-making
audience, in which there is often a need to rapidly grasp key
evidential and interpretive information from a broad evidence-
base. The technique is inevitably constrained by what is reported
in existing reviews and by the time lag between generation of
primary literature and secondary literature. In a heterogeneous
and fast moving field such as telehealthcare, a balance must also be
struck between the desire to capture new publications and the
need to appraise them in sufficient detail for meaningful
conclusions to be drawn.
Understanding the ‘why’ factors in telehealthcare is critical for
informing future programmes, yet many reviews provide only
basic descriptions of the telehealthcare interventions, making it
difficult to assess which components may have been most critical
in determining its success or otherwise. Despite the preliminary
work undertaken to define telehealthcare, difficulties arose with
inconsistent terminology across reviews and a general lack of
precision in the descriptions of telehealthcare in the individual
reviews [13]. The implementation of telehealthcare often requires
organisational redesign which may exacerbate or reform existing
system inefficiencies and uncover new ones. As such, it becomes
hard to disentangle the effects of the technology from the human
and organisational processes that surround it. In this setting,
telehealthcare should be considered as an example of a complex
intervention and, as such, may require a more innovative
approach to research [99,100]. A full description of the
intervention is an essential part of this, and may need to be
combined with qualitative approaches in addition to the classic
randomised controlled trial. The technique of ‘‘realistic evalua-
tion’’ – where mid-range theories structured around emergent
context-mechanism-outcome (CMO) groupings – are then sup-
ported or refuted by further scrutiny of the evidence, holds
significant potential for the further understanding of telehealthcare
[101,102,103,104].
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Comparisons with Other Literature
Many studies took place with enthusiastic supporters using
home-grown technologies and the observed benefits may not
therefore be replicable in other contexts, or when scaled-up for use
in routine settings [105,106,107,108].
In the UK, the potential benefits of telehealthcare at scale were
addressed in the recent NHS Whole System Demonstrator (WSD)
Project. This randomised controlled trial incorporated telemoni-
toring for 6000 patients with COPD, heart failure and other
chronic illnesses [109]. The WSD appeared to show significant
reductions in mortality and health service utilisation between the
intervention and control groups, although later reports indicate
that the costs of delivery may have outweighed potential savings
[110]. Selection bias may also have influenced the results, as only
20% of those initially interviewed during recruitment to the trial
were cleared for participation, while the potential influence of
political drivers has also raised questions about the results [111]. A
recently published evaluation of quality of life and psychological
outcomes reported no benefit of telehealthcare over usual care in
patients with heart failure or COPD, although there were also no
deleterious effects. [112] An economic analysis revealed an
increase in Quality Adjusted Life Years for patients in both trial
arms, although the cost of this increase was significantly greater for
the telehealth arm, leading the authors to conclude that
telehealthcare was not cost effective [113].
Another large trial in the United States, casts some doubt on the
positive impacts of telehealthcare in heart failure when imple-
mented at scale. This trial followed over 1600 patients with heart
failure randomised between an interactive voice response tele-
monitoring system and usual care. There was no difference in
hospital readmissions or deaths in the groups at six months [106].
A way forward for telehealthcare in heart failure, focusing on
personalisation of care and crisis prevention, has been outlined by
Anker et al [114].
Largely absent from the systematic review literature on
telehealthcare is a consideration of patient preferences. There
are policy pressures to shift to lower-cost models of care and this
may not suit all patients. Early discussion with patients regarding
whether they have the right to refuse telehealthcare and demand a
face-to-face consultation may help to avoid possible unintended
consequences of service redesign, such as increased emergency
department use.
The telehealthcare literature also suffers from the poor
representation of particular groups, such as those with multiple
comorbidities, cognitive impairment, disabilities or social prob-
lems. Although these are often considered in the context of social
‘telecare’, it is important for telehealthcare planners and
researchers to also respond to these needs. The equity dilemma
is compounded by the so called ‘Digital Health Divide’, whereby
socioeconomically disadvantaged groups with the highest health
care needs also have poorer technology access and lack the skills to
take advantage of eHealth resources [115]. Without addressing
this tension there is the risk that implementing telehealthcare may
perversely widen health inequalities [116].
We did not find much discussion of data security and privacy
issues among these systematic reviews, although we acknowledge
that this typically appears in other types of literature. Nonetheless
it is important to highlight the potential risks of telehealth data
transmission for patient confidentiality and the risks of network
vulnerability for patient safety [117,118,119].
Implications for Policy, Practice and Future Research
The findings of this systematic overview raise a number of
important considerations for future policy, procurement and
research in telehealthcare. The reviews that we have considered
encompass a large number of evaluation projects but, like the
services they describe, these are rarely scaled to produce large,
high quality studies of sufficient duration to determine long term
sustainability and impacts. While reported improvements in
surrogate clinical endpoints and hospitalisations are encouraging,
the evidence overall remains equivocal. Despite the promise that
telehealthcare will generate cost-savings for healthcare organisa-
tions, governments and society in an ageing population, the
economic evidence base is weak and fails to take account of the
patient and societal perspective or consider downstream effects on
the distribution of care services.
Since the systematic reviews we have included prioritised
quantitative evaluations, there was less discussion of sociotechnical
factors underpinning successful or unsuccessful telehealth services
than appears in other types of telehealth research literature.
Introducing telehealthcare typically requires the redesign of
services and customisation to suit contextual requirements. There
needs to be a thorough consideration of who will be affected and
how, and efforts made to predict and mitigate potentially negative
unforeseen consequences, along with the provision of adequate
resources and plans for evaluation and sustainability. In terms of
practice, user-friendly and unobtrusive technology is more likely to
be easily implemented [35]. And, critically, there needs to be
adequate organisation of workflow to allow quick responses to
alerts from the technology alongside planned standard interven-
tions [35].
Future research should include trials with longer-term follow-up
and comprehensive economic evaluations in order to evidence the
value of telehealth to consumers and health services and to
demonstrate return on investment. The randomised controlled
trial has the short-coming that it cannot be blinded when
delivering telehealthcare and in such circumstances randomised
crossover trials may be more appropriate. In order to address the
speed of technological change in this area, there is also a need for
new evaluative approaches such as ‘‘tracker trials’’ which allow for
the evolution of technology projects within the study period in
order to maximise the meaningfulness of the results and for
informing policies and strategies for implementation [120].
There is also a need for extensive contextual information to be
collected and reported on interventions to improve the evidence
base. A shared taxonomy for classifying different telehealth
interventions, better description of intervention components, and
agreement on common outcome measures, assessment tools and
metrics, would all help to strengthen the evidence-base by
facilitating the synthesis of results across studies and enabling
their interpretation with reference to shared and unique factors.
Conclusions
There is now a very large volume of work investigating the use
of a range of telehealthcare delivery models in a number of clinical
contexts. Governments and industry have expressed great
enthusiasm for these interventions in light of their potential to
help manage the increased care demands of an ageing population
[9,10]. On examination, the evidence for favourable impacts on
clinical endpoints is modest and measured over the short-term but
it appears that telehealthcare can improve outcomes in patients
with more severe illness who have most to gain. Telehealthcare
also seems to be most successful where the intervention is
integrated with education and intensive telemonitoring rather
than via simple telephone support. The evidence for cost-savings –
the proposition most often used to justify the implementation of
telehealthcare – has rarely been generated through robust
economic evaluations.
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The potential for learning from published studies is also limited
due to a lack of emphasis on understanding why interventions
succeed or fail. It is critically important to recognise that the term
telehealthcare may describe a range of intervention packages
implemented in real healthcare organisations and should ideally be
studied as part of a complex sociotechnical system. Research
should therefore be interdisciplinary and its results used to inform
further configuration of services. This is particularly important
given the fast pace of technological change in this area, where
pressures to adopt new interventions often outpace efforts to
accumulate the scientific evidence necessary to demonstrate their
value.
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